{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T18:39:57Z","timestamp":1792435197687,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":96,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NSFC82473235"],"award-info":[{"award-number":["NSFC82473235"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16539-5","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T06:19:22Z","timestamp":1784096362000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dosimetric superiority of proton radiosurgery in liver cancer: an in silico comparative dosimetric study"],"prefix":"10.1186","volume":"26","author":[{"given":"Jiaran","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changxing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongdong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuanghu","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"16539_CR1","doi-asserted-by":"crossref","unstructured":"Lane SA, Slater JM, Yang GY. Image-Guided Proton Therapy: A Comprehensive Review. Cancers (Basel). 2023;15(9).","DOI":"10.3390\/cancers15092555"},{"key":"16539_CR2","doi-asserted-by":"crossref","unstructured":"Santos A, Penfold S, Gorayski P, Le H. The Role of Hypofractionation in Proton Therapy. Cancers (Basel). 2022;14(9).","DOI":"10.3390\/cancers14092271"},{"issue":"6","key":"16539_CR3","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1002\/hep.30591","volume":"69","author":"K Hara","year":"2019","unstructured":"Hara K, Takeda A, Tsurugai Y, Saigusa Y, Sanuki N, Eriguchi T, et al. Radiotherapy for Hepatocellular Carcinoma Results in Comparable Survival to Radiofrequency Ablation: A Propensity Score Analysis. Hepatology. 2019;69(6):2533\u201345.","journal-title":"Hepatology"},{"issue":"2","key":"16539_CR4","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.ijrobp.2009.08.020","volume":"78","author":"KA Goodman","year":"2010","unstructured":"Goodman KA, Wiegner EA, Maturen KE, Zhang Z, Mo Q, Yang G, et al. Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies. Int J Radiat Oncol Biol Phys. 2010;78(2):486\u201393.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"16539_CR5","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1200\/JCO.2001.19.1.164","volume":"19","author":"KK Herfarth","year":"2001","unstructured":"Herfarth KK, Debus J, Lohr F, Bahner ML, Rhein B, Fritz P, et al. Stereotactic single-dose radiation therapy of liver tumors: results of a phase I\/II trial. J Clin Oncol. 2001;19(1):164\u201370.","journal-title":"J Clin Oncol"},{"key":"16539_CR6","doi-asserted-by":"crossref","unstructured":"Kim K, Yu JI, Park HC, Yoo GS, Lim DH, Noh JM et al. A phase II trial of hypofractionated high-dose proton beam therapy for unresectable liver metastases. Radiother Oncol. 2022;176.","DOI":"10.1016\/j.radonc.2022.09.003"},{"issue":"5","key":"16539_CR7","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1007\/s11547-025-01988-y","volume":"130","author":"M Bilski","year":"2025","unstructured":"Bilski M, Korab K, Orzechowska M, Ponikowska J, Cisek P, Jereczek-Fossa BA, et al. Comprehensive cohort study: computer tomography-guided high-dose rate brachytherapy as metastasis-directed therapy for liver metastases from colorectal cancer in repeat oligoprogression. Radiol Med. 2025;130(5):694\u2013705.","journal-title":"Radiol Med"},{"issue":"3","key":"16539_CR8","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.ijrobp.2017.02.095","volume":"98","author":"T-S Su","year":"2017","unstructured":"Su T-S, Liang P, Liang J, Lu H-Z, Jiang H-Y, Cheng T, et al. Long-Term Survival Analysis of Stereotactic Ablative Radiotherapy Versus Liver Resection for Small Hepatocellular Carcinoma. Int J Radiat Oncol Biol Phys. 2017;98(3):639\u201346.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"16539_CR9","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.jhep.2020.09.026","volume":"74","author":"TH Kim","year":"2020","unstructured":"Kim TH, Koh YH, Kim BH, Kim MJ, Lee JH, Park B, et al. Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: A randomized phase III trial. J Hepatol. 2020;74(3):603\u201312.","journal-title":"J Hepatol"},{"issue":"1","key":"16539_CR10","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.prro.2021.09.004","volume":"12","author":"S Apisarnthanarax","year":"2022","unstructured":"Apisarnthanarax S, Barry A, Cao M, Czito B, DeMatteo R, Drinane M, et al. External Beam Radiation Therapy for Primary Liver Cancers: An ASTRO Clinical Practice Guideline. Pract Radiat Oncol. 2022;12(1):28\u201351.","journal-title":"Pract Radiat Oncol"},{"issue":"4","key":"16539_CR11","first-page":"316","volume":"102","author":"L Leksell","year":"1951","unstructured":"Leksell L. The stereotaxic method and radiosurgery of the brain. Acta Chir Scand. 1951;102(4):316\u20139.","journal-title":"Acta Chir Scand"},{"issue":"4","key":"16539_CR12","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.otc.2009.04.003","volume":"42","author":"JM Lasak","year":"2009","unstructured":"Lasak JM, Gorecki JP. The history of stereotactic radiosurgery and radiotherapy. Otolaryngol Clin North Am. 2009;42(4):593\u20139.","journal-title":"Otolaryngol Clin North Am"},{"issue":"4","key":"16539_CR13","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1007\/s12072-022-10339-2","volume":"16","author":"K Su","year":"2022","unstructured":"Su K, Gu T, Xu K, Wang J, Liao H, Li X, et al. Gamma knife radiosurgery versus transcatheter arterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a propensity score matching study. Hepatol Int. 2022;16(4):858\u201367.","journal-title":"Hepatol Int"},{"issue":"4","key":"16539_CR14","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.ijrobp.2015.07.2260","volume":"93","author":"GMM Videtic","year":"2015","unstructured":"Videtic GMM, Hu C, Singh AK, Chang JY, Parker W, Olivier KR, et al. A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer: NRG Oncology RTOG 0915 (NCCTG N0927). Int J Radiat Oncol Biol Phys. 2015;93(4):757\u201364.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"16539_CR15","doi-asserted-by":"publisher","first-page":"110223","DOI":"10.1016\/j.radonc.2024.110223","volume":"194","author":"F Liu","year":"2024","unstructured":"Liu F, Brown DR, Munley MT. Optimal hypofractionated radiation therapy schemes for early-stage hepatocellular carcinoma. Radiother Oncol. 2024;194:110223.","journal-title":"Radiother Oncol"},{"issue":"1","key":"16539_CR16","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1245\/s10434-015-4579-z","volume":"23","author":"JJ Meyer","year":"2016","unstructured":"Meyer JJ, Foster RD, Lev-Cohain N, Yokoo T, Dong Y, Schwarz RE, et al. A Phase I Dose-Escalation Trial of Single-Fraction Stereotactic Radiation Therapy for Liver Metastases. Ann Surg Oncol. 2016;23(1):218\u201324.","journal-title":"Ann Surg Oncol"},{"key":"16539_CR17","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.addr.2016.11.006","volume":"109","author":"R Mohan","year":"2016","unstructured":"Mohan R, Grosshans D. Proton therapy - Present and future. Adv Drug Deliv Rev. 2016;109:26\u201344.","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"16539_CR18","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.ijrobp.2023.09.049","volume":"118","author":"RC-E Hsieh","year":"2024","unstructured":"Hsieh RC-E, Lee C-H, Huang H-C, Wu S-W, Chou C-Y, Hung S-P, et al. Clinical and Dosimetric Results of Proton or Photon Radiation Therapy for Large (>\u20095\u00a0cm) Hepatocellular Carcinoma: A Retrospective Analysis. Int J Radiat Oncol Biol Phys. 2024;118(3):712\u201324.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"16539_CR19","doi-asserted-by":"publisher","first-page":"277","DOI":"10.14338\/IJPT-16-00010.1","volume":"3","author":"G Mondlane","year":"2016","unstructured":"Mondlane G, Gubanski M, Lind PA, Henry T, Ureba A, Siegbahn A. Dosimetric Comparison of Plans for Photon- or Proton-Beam Based Radiosurgery of Liver Metastases. Int J Part Ther. 2016;3(2):277\u201384.","journal-title":"Int J Part Ther"},{"key":"16539_CR20","doi-asserted-by":"crossref","unstructured":"Timmerman R. A Story of Hypofractionation and the Table on the Wall. Int J Radiat Oncol Biol Phys. 2022;112(1).","DOI":"10.1016\/j.ijrobp.2021.09.027"},{"issue":"5","key":"16539_CR21","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.ijrobp.2020.04.027","volume":"107","author":"J Pursley","year":"2020","unstructured":"Pursley J, El Naqa I, Sanford NN, Noe B, Wo JY, Eyler CE, et al. Dosimetric Analysis and Normal-Tissue Complication Probability Modeling of Child-Pugh Score and Albumin-Bilirubin Grade Increase After Hepatic Irradiation. Int J Radiat Oncol Biol Phys. 2020;107(5):986\u201395.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"16539_CR22","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.prro.2015.01.004","volume":"5","author":"SJ Gandhi","year":"2015","unstructured":"Gandhi SJ, Liang X, Ding X, Zhu TC, Ben-Josef E, Plastaras JP, et al. Clinical decision tool for optimal delivery of liver stereotactic body radiation therapy: Photons versus protons. Pract Radiat Oncol. 2015;5(4):209\u201318.","journal-title":"Pract Radiat Oncol"},{"key":"16539_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.phro.2018.11.004","volume":"8","author":"WT Arscott","year":"2018","unstructured":"Arscott WT, Thompson RF, Yin L, Burgdorf B, Kirk M, Ben-Josef E. Stereotactic body proton therapy for liver tumors: Dosimetric advantages and their radiobiological and clinical implications. Phys Imaging Radiat Oncol. 2018;8:17\u201322.","journal-title":"Phys Imaging Radiat Oncol"},{"key":"16539_CR24","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1748-717X-8-48","volume":"8","author":"C Toramatsu","year":"2013","unstructured":"Toramatsu C, Katoh N, Shimizu S, Nihongi H, Matsuura T, Takao S, et al. What is the appropriate size criterion for proton radiotherapy for hepatocellular carcinoma? A dosimetric comparison of spot-scanning proton therapy versus intensity-modulated radiation therapy. Radiat Oncol. 2013;8:48.","journal-title":"Radiat Oncol"},{"key":"16539_CR25","doi-asserted-by":"publisher","first-page":"1478872","DOI":"10.3389\/fonc.2024.1478872","volume":"14","author":"M Bilski","year":"2024","unstructured":"Bilski M, Peszy\u0144ska-Piorun M, Konat-B\u0105ska K, Brzozowska A, Korab K, Wojtyna E, et al. Radiotherapy as a metastasis directed therapy for liver oligometastases - comparative analysis between CT-guided interstitial HDR brachytherapy and two SBRT modalities performed on double-layer and single layer LINACs. Front Oncol. 2024;14:1478872.","journal-title":"Front Oncol"},{"key":"16539_CR26","first-page":"100815","volume":"48","author":"M Bilski","year":"2024","unstructured":"Bilski M, Korab K, St\u0105p\u00f3r-Fudzi\u0144ska M, Ponikowska J, Brzozowska A, Sroka \u0141, et al. HDR brachytherapy versus robotic-based and linac-based stereotactic ablative body radiotherapy in the treatment of liver metastases - A dosimetric comparison study of three radioablative techniques. Clin Transl Radiat Oncol. 2024;48:100815.","journal-title":"Clin Transl Radiat Oncol"},{"issue":"5","key":"16539_CR27","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1016\/j.ijrobp.2020.12.012","volume":"109","author":"MR Folkert","year":"2021","unstructured":"Folkert MR, Meyer JJ, Aguilera TA, Yokoo T, Sanford NN, Rule WG, et al. Long-Term Results of a Phase 1 Dose-Escalation Trial and Subsequent Institutional Experience of Single-Fraction Stereotactic Ablative Radiation Therapy for Liver Metastases. Int J Radiat Oncol Biol Phys. 2021;109(5):1387\u201395.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"16539_CR28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ejca.2016.04.008","volume":"62","author":"EH Quik","year":"2016","unstructured":"Quik EH, Feenstra TL, Postmus D, Slotman BJ, Leemans CR, Krabbe PFM, et al. Individual patient information to select patients for different radiation techniques. Eur J Cancer. 2016;62:18\u201327.","journal-title":"Eur J Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16539-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16539-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16539-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T18:03:12Z","timestamp":1792432992000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16539-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16539"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16539-5","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"assertion":[{"value":"2 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was endorsed by the Ethical Review Board of the First Affiliated Hospital of University of Science and Technology of China (ethics approval number: 2025KY-NO.431), and a waiver for the written informed consent was waived by this Ethical Review Board.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1248"}}